Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart

Saul Schaefer, Joel Gober, Gregory S. Karczmar, Gerald B. Matson, Michael W. Weiner

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Phosphorus-31 nuclear magnetic resonance spectroscopy can determine the status of high energy phosphates in vivo. However, its application to human cardiac studies requires precise spatial localization without significant contamination from other tissues. Using image-selected in-vivo spectroscopy (ISIS), a technique that allows three-dimensional localization of the volume of interest, 12 subjects were studied to determine the feasibility and reproducibility of phosphorus-31 spectroscopy of the human heart. Nuclear magnetic resonance imaging was performed using a commercial 1.5 tesla system to define the volume of interest. Phosphorus-31 spectra were obtained from the septum and anteroapical region of the left ventricle in 10 studies. Relative peak heights and areas were determined for high energy phosphates. The mean phosphocreatine to adenosine triphosphate ratio was 1.33 ± 0.19 by height analysis and 1.23 ± 0.27 by area analysis. Duplicate measurements in four subjects showed a reproducibility of ≤10% in three of the subjects. All spectra showed significant signal contribution from the 2,3 diphosphoglycerate in chamber red cells without evidence of skeletal muscle contamination. These results demonstrate the feasibility of imageguided phosphorus-31 spectroscopy for human cardiac studies and indicate the potential of this technique to study metabolic disturbances in human myocardial disease.

Original languageEnglish (US)
Pages (from-to)1449-1455
Number of pages7
JournalJournal of the American College of Cardiology
Volume12
Issue number6
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Phosphorus
Spectrum Analysis
Magnetic Resonance Spectroscopy
Magnetic Resonance Imaging
Phosphates
2,3-Diphosphoglycerate
Phosphocreatine
Cardiomyopathies
Heart Ventricles
Skeletal Muscle
Adenosine Triphosphate

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart. / Schaefer, Saul; Gober, Joel; Karczmar, Gregory S.; Matson, Gerald B.; Weiner, Michael W.

In: Journal of the American College of Cardiology, Vol. 12, No. 6, 1988, p. 1449-1455.

Research output: Contribution to journalArticle

Schaefer, Saul ; Gober, Joel ; Karczmar, Gregory S. ; Matson, Gerald B. ; Weiner, Michael W. / Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart. In: Journal of the American College of Cardiology. 1988 ; Vol. 12, No. 6. pp. 1449-1455.
@article{c917419cc7bb400fa29d56d6816ffb57,
title = "Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart",
abstract = "Phosphorus-31 nuclear magnetic resonance spectroscopy can determine the status of high energy phosphates in vivo. However, its application to human cardiac studies requires precise spatial localization without significant contamination from other tissues. Using image-selected in-vivo spectroscopy (ISIS), a technique that allows three-dimensional localization of the volume of interest, 12 subjects were studied to determine the feasibility and reproducibility of phosphorus-31 spectroscopy of the human heart. Nuclear magnetic resonance imaging was performed using a commercial 1.5 tesla system to define the volume of interest. Phosphorus-31 spectra were obtained from the septum and anteroapical region of the left ventricle in 10 studies. Relative peak heights and areas were determined for high energy phosphates. The mean phosphocreatine to adenosine triphosphate ratio was 1.33 ± 0.19 by height analysis and 1.23 ± 0.27 by area analysis. Duplicate measurements in four subjects showed a reproducibility of ≤10{\%} in three of the subjects. All spectra showed significant signal contribution from the 2,3 diphosphoglycerate in chamber red cells without evidence of skeletal muscle contamination. These results demonstrate the feasibility of imageguided phosphorus-31 spectroscopy for human cardiac studies and indicate the potential of this technique to study metabolic disturbances in human myocardial disease.",
author = "Saul Schaefer and Joel Gober and Karczmar, {Gregory S.} and Matson, {Gerald B.} and Weiner, {Michael W.}",
year = "1988",
doi = "10.1016/S0735-1097(88)80008-1",
language = "English (US)",
volume = "12",
pages = "1449--1455",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart

AU - Schaefer, Saul

AU - Gober, Joel

AU - Karczmar, Gregory S.

AU - Matson, Gerald B.

AU - Weiner, Michael W.

PY - 1988

Y1 - 1988

N2 - Phosphorus-31 nuclear magnetic resonance spectroscopy can determine the status of high energy phosphates in vivo. However, its application to human cardiac studies requires precise spatial localization without significant contamination from other tissues. Using image-selected in-vivo spectroscopy (ISIS), a technique that allows three-dimensional localization of the volume of interest, 12 subjects were studied to determine the feasibility and reproducibility of phosphorus-31 spectroscopy of the human heart. Nuclear magnetic resonance imaging was performed using a commercial 1.5 tesla system to define the volume of interest. Phosphorus-31 spectra were obtained from the septum and anteroapical region of the left ventricle in 10 studies. Relative peak heights and areas were determined for high energy phosphates. The mean phosphocreatine to adenosine triphosphate ratio was 1.33 ± 0.19 by height analysis and 1.23 ± 0.27 by area analysis. Duplicate measurements in four subjects showed a reproducibility of ≤10% in three of the subjects. All spectra showed significant signal contribution from the 2,3 diphosphoglycerate in chamber red cells without evidence of skeletal muscle contamination. These results demonstrate the feasibility of imageguided phosphorus-31 spectroscopy for human cardiac studies and indicate the potential of this technique to study metabolic disturbances in human myocardial disease.

AB - Phosphorus-31 nuclear magnetic resonance spectroscopy can determine the status of high energy phosphates in vivo. However, its application to human cardiac studies requires precise spatial localization without significant contamination from other tissues. Using image-selected in-vivo spectroscopy (ISIS), a technique that allows three-dimensional localization of the volume of interest, 12 subjects were studied to determine the feasibility and reproducibility of phosphorus-31 spectroscopy of the human heart. Nuclear magnetic resonance imaging was performed using a commercial 1.5 tesla system to define the volume of interest. Phosphorus-31 spectra were obtained from the septum and anteroapical region of the left ventricle in 10 studies. Relative peak heights and areas were determined for high energy phosphates. The mean phosphocreatine to adenosine triphosphate ratio was 1.33 ± 0.19 by height analysis and 1.23 ± 0.27 by area analysis. Duplicate measurements in four subjects showed a reproducibility of ≤10% in three of the subjects. All spectra showed significant signal contribution from the 2,3 diphosphoglycerate in chamber red cells without evidence of skeletal muscle contamination. These results demonstrate the feasibility of imageguided phosphorus-31 spectroscopy for human cardiac studies and indicate the potential of this technique to study metabolic disturbances in human myocardial disease.

UR - http://www.scopus.com/inward/record.url?scp=0023768572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023768572&partnerID=8YFLogxK

U2 - 10.1016/S0735-1097(88)80008-1

DO - 10.1016/S0735-1097(88)80008-1

M3 - Article

VL - 12

SP - 1449

EP - 1455

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 6

ER -